5 papers about lung cancer suggested by Stephen Liu
Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:
First-line chemo-immunotherapy in SCLC: outcomes of a binational real-world study
Authors: L. Moliner et al.
Authors: Dae-Ho Choi et al.
Authors: Mehraab N. Majeed, Subramanian Venkatesan, Dionysis Papadatos-Pastos, Tanya Ahmad, Martin Forster, Polyvios Demetriades, Daniel Johnathan Hughes, Sarah Benafif, Siow-Ming Lee
Real-world outcomes of pralsetinib in RET fusion-positive non-small cell lung cancer
Authors: Francesca Lucibello et al.
Authors: Anne S. Tsao et al.
Follow Stephen Liu on X for more such content.
Stephen V Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.
His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023